| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |